Rochester,NY 8/13/2009 11:36:32 PM
Dyax Corp.DYAX-at the Canaccord Adams Global Growth Conference
Dyax Corp
Dyax Corp., a developer of novel biotherapeutics for unmet medical needs, declared on Aug 10, 2009 that Ivana Magovcevic-Liebisch, Executive Vice President of Administration and General Counsel of Dyax, will present at the 29th Annual Canaccord Adams Global Growth Conference, being held August 11-13th at The Intercontinental Hotel in Boston, MA.
http://StockEinstein.com offers free daily stock alerts on companies ready to run. Scroll to the bottom of this page to signup for free stock alerts and visit our site.
Dyax is focused on advancing novel biotherapeutics for unmet medical needs, with an emphasis on inflammatory and oncology indications. Dyax uses its proprietary drug discovery technology to identify antibody, small protein and peptide compounds for clinical development.
StockEinstein.com has a dedicated team uncovering stocks ready to break and run. We apply time tested criteria and when one of these stocks meets or exceeds our benchmarks, our subscribers are immediately notified directly to their in-box.
This is a free service available only to our subscribers. Scroll to the bottom of this page to signup for free stock alerts and visit our site.
During 2009 our alerts have resulted in an average price gain of 80%+.
Disclaimer: Full disclaimer at http://StockEinstein.com/disclaimer.php
IMPORTANT: Never invest in any stock featured in any press release, email or website unless you can afford the loss of your entire investment. Stocks and particularly penny stocks have the possibility for dramatic gains, and also losses. Neither StockEinstein, nor any of its affiliates are registered investment advisors or broker dealers.
